Advia 120 Hematology System, In Vitro Diagnostic System
Counter, Cell, Automated (Particle Counter). 510(k) K971998, from Bayer Corp. (Tarrytown, NY). Product code GKL, class 2.
As of Nov 20, 2026, K971998 is an FDA 510(k) held by Bayer Corp., substantially equivalent on Aug 29, 1997 after 91 days, with 2 recalls tied to it in FDA's recall database.
- Review time: 91 days
- Recalls: 2
- Cited as a predicate by: 4 devices
The ADVIA 120 Hematology System is a quantitative, automated hematology analyzer that provides a leukocyte differential count and reticulocyte analysis for in vitro diagnostic use in clinical laboratories.
- Ret-He Parameter On The Sysmex Model XE-2100 Automated Hematology AnalyzerK050589 · Sysmex America, Inc. · May 4, 2005
- Bayer Advia 2120 Hematology Analyzer With Autoslide SystemK042251 · Bayer Healthcare, LLC · Sep 17, 2004
- Advia 120 Hematology System Complete Blood Count (Cbc) MethodK022668 · Bayer Diagnostics Corp. · Oct 15, 2002
- Advia 120 Hematology System, Cyanide-Free High DeterminationK012904 · Bayer Diagnostics Corp. · Sep 21, 2001
| Jun 26, 2013 | Z-2114-2013The ADVIA 120 optics cover or hood is located on the very top of the ADVIA 120 analyzer. When the optics cover is raised, it is supported by two gas struts (SMN 10309266) attached to the cover on the left and right… | Terminated |
| Mar 16, 2006 | Z-1376-06The ADVIA 2120 has reported ; highly intermittent low results on all primary results: White Blood Cells (WBC), Red Blood Cells (RBC), Hemoglobin (HGB) and Platelets (PLT) and an abnormal baso cytogram. | Terminated |
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 30, 1997
- Review panel
- Hematology
- Regulation
- 21 CFR 864.5200
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files